4
Changes in Ownership
Edesa Biotech, Inc. Filed Acc 0001213900-23-002248
10% owner sold 297,474 shares at an average $2.65 ($787,716)
From the SEC's structured data for this filing
Trades in this filing
van der Velden Peter · 10% owner
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-09 | Sale : show line 1 in the form | −132,845 | $2.66 | $353,647 | 1,764,583 | I |
| 2023-01-09 | Sale : show line 2 in the form | −12,284 | $2.66 | $32,701 | 163,170 | I |
| 2023-01-10 | Sale : show line 3 in the form | −139,450 | $2.63 | $367,395 | 1,625,133 | I |
| 2023-01-10 | Sale : show line 4 in the form | −12,895 | $2.63 | $33,973 | 150,275 | I |
| Open-market sales · 297,474 sh · avg $2.65 · $787,716 | ||||||
Loading xslF345X03/ownership.xml…